These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4290697)

  • 1. [Biochemical studies on the phenotype of cancer cells].
    Sugimura T
    Saishin Igaku; 1966 May; 21(5):1115-8. PubMed ID: 4290697
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical phenotype in human and animal liver tumors.
    Prajda N
    Prog Clin Biol Res; 1983; 132D():79-88. PubMed ID: 6314369
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between quantitative expression of protein p120 and proliferative activity in cancer cells.
    Trerè D; Montanaro L; Migaldi M; Pession A; Derenzini M
    Eur J Histochem; 1997; 41 Suppl 2():151-2. PubMed ID: 9859826
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the biochemistry of tumor cells].
    Wieland O
    Munch Med Wochenschr; 1966 Aug; 108(34):1653-61. PubMed ID: 4295576
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship of cholesterol biosynthesis to cancer.
    Siperstein MD
    Trans Am Clin Climatol Assoc; 1972; 83():156-64. PubMed ID: 4340647
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytological and comparative biochemical studies on normal and neoplastic earthworm tissues.
    Hancock RL
    Natl Cancer Inst Monogr; 1969 Jul; 31():593-643. PubMed ID: 4315899
    [No Abstract]   [Full Text] [Related]  

  • 7. Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in hepatocellular carcinoma and metastatic liver cancer.
    Hotta T; Kobayashi Y; Taniguchi K; Johata K; Sahara M; Watanabe T; Ochiai M; Tanimura H; Tsubota YT
    Oncol Rep; 2004 Aug; 12(2):347-51. PubMed ID: 15254700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical studies on the DAB-hepatocarcinogenesis. Comparative studies on normal rat liver, AH 130 ascites hepatoma and 3'-me-DAB-hepatoma especially at the level of subcellular particulates.
    SATO K
    Sci Rep Res Inst Tohoku Univ Med; 1961 Sep; 10():249-63. PubMed ID: 14038965
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone marrow cells: the source of hepatocellular carcinoma?
    Wu XZ; Yu XH
    Med Hypotheses; 2007; 69(1):36-42. PubMed ID: 17300877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of des-gamma-carboxy prothrombin levels in cancer and non-cancer tissue in patients with hepatocellular carcinoma.
    Yuan LW; Tang W; Kokudo N; Sugawara Y; Karako H; Hasegawa K; Aoki T; Kyoden Y; Deli G; Li YG; Makuuchi M
    Oncol Rep; 2004 Aug; 12(2):269-73. PubMed ID: 15254687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KL-6 mucin in metastatic liver cancer tissues from primary colorectal carcinoma.
    Zhang K; Tang W; Qu X; Guo Q; Inagaki Y; Seyama Y; Abe H; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
    Hepatogastroenterology; 2009; 56(93):960-3. PubMed ID: 19760920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylase activity in rat hepatoma and mouse mammary carcinoma transplants.
    GORANSON ES; McBRIDE J; WEBER G
    Cancer Res; 1954 Mar; 14(3):227-31. PubMed ID: 13150338
    [No Abstract]   [Full Text] [Related]  

  • 13. The Sialyl Lewis X expression in hepatocarcinogenesis: potential predictor for the emergence of hepatocellular carcinoma.
    Fujiwara Y; Shimada M; Takenaka K; Kajiyama K; Shirabe K; Sugimachi K
    Hepatogastroenterology; 2002; 49(43):213-7. PubMed ID: 11941958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma.
    Zhang HM; Zhang LW; Liu WC; Cheng J; Si XM; Ren J
    Cytotherapy; 2006; 8(6):580-8. PubMed ID: 17148035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and significance of lipoprotein(a) in hepatocellular carcinoma.
    Jiang JT; Wu CP; Xu N; Zhang XG
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):25-8. PubMed ID: 19208510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concerning pathways of glucose utilization in mouse liver and hepatoma.
    ABRAHAM S; HILL R; CHAIKOFF IL
    Cancer Res; 1955 Mar; 15(3):177-80. PubMed ID: 14352211
    [No Abstract]   [Full Text] [Related]  

  • 17. Golgi protein 73 as a biomarker of hepatocellular cancer: development of a quantitative serum assay and expression studies in hepatic and extrahepatic malignancies.
    Fimmel CJ; Wright L
    Hepatology; 2009 May; 49(5):1421-3. PubMed ID: 19402061
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter.
    Salnikov AV; Kusumawidjaja G; Rausch V; Bruns H; Gross W; Khamidjanov A; Ryschich E; Gebhard MM; Moldenhauer G; Büchler MW; Schemmer P; Herr I
    Cancer Lett; 2009 Mar; 275(2):185-93. PubMed ID: 19026485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nuclear ribonucleic acids of cancer cells].
    Piker EG; Likhtenshteĭn AV; Shapot VS; Rodionova NP
    Vestn Akad Med Nauk SSSR; 1968; 23(3):26-30. PubMed ID: 4317933
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical studies of liver tumors of children.
    Murthy AS; Vawter GF; Kopito L; Rossen E
    Arch Pathol; 1973 Jul; 96(1):48-52. PubMed ID: 4350621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.